Evidence map›Paper›PMID 30643708›Full record

ArticleCurrent addiction reports2018

Cannabis and Mood Disorders.

Aliya M Lucatch, Alexandria S Coles, Kevin P Hill, Tony P George

Abstract read
In one paragraph

Article in Current addiction reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Adverse Impact of Cannabis on Human Health.Annual review of medicine · 2024
    Review
  9. The Association Between Tobacco and Cannabis Use and the Age of Onset of Depression and Anxiety Symptoms: Among Adolescents and Young Adults.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Aliya M LucatchAddictions Division, Centre for Addictions and Mental Health (CAMH), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA USA.
Alexandria S ColesAddictions Division, Centre for Addictions and Mental Health (CAMH), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA USA.
Kevin P HillDivision of Addiction Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA USA.
Tony P GeorgeAddictions Division, Centre for Addictions and Mental Health (CAMH), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA USA.
Centre for Addiction and Mental Health · CAHarvard University · USUniversity of Toronto · CA

Funding

Effects of rTMS on Cannabis Use and Cognitive Outcomes in SchizophreniaR21DA043949 · NIDA · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI GEORGE, TONY P · 2017 to 2018
$286k
NIDA NIH HHS R21 DA043949
6 · The paper itself

Abstract

purpose of reviewThe present review will provide an overview of the neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) in mood disorders. RECENT

findingsPatients with mood disorders including major depressive disorder (MDD) and bipolar disorder (BD) have higher rates of cannabis use, and CUD compared to the general population. Reasons for this association are not clear, nor are the putative therapeutic effects of cannabis use, or its components delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), in these illnesses. The evidence surrounding treatments for patients with this comorbidity is lacking, with more support for psychotherapeutic treatments compared with pharmacological treatments. SUMMARY: Cannabis use may be associated mood disorders, but more research is needed to increase our understanding of the mechanisms for this association, and to develop more effective treatments for this comorbidity.

Indexed as

AntidepressantsBipolar DisorderCannabisCannabis Use DisorderMajor DepressionMood DisordersMood Stabilizers

Identifiers

PMID30643708
PMCPMC6329464
OpenAlexW2803082720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.